Arvi Rauk

Dr. Arvi Rauk


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2009 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
ARArvi Rauk
Arvi Rauk
The chemistry of Alzheimer’s disease is largely centred on the amyloid β-peptide, its formation, structure, and interactions with metals, membranes, proteins and other species. This critical review summarizes the current state of knowledge (252 references).


3 November 2005 in JBIC Journal of Biological Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
DRDuilio F. Raffa
Duilio F. Raffa
RGRodolfo Gómez-Balderas
Rodolfo Gómez-Balderas
PBPatrick Brunelle
Patrick Brunelle
GRGail A. Rickard
Gail A. Rickard
ARArvi Rauk
Arvi Rauk

30 September 2006 in JBIC Journal of Biological Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
DRDuilio F. Raffa
Duilio F. Raffa
GRGail A. Rickard
Gail A. Rickard
ARArvi Rauk
Arvi Rauk

13 August 2003 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
DRDarren L. Reid
Darren L. Reid
DADavid A. Armstrong
David A. Armstrong
ARArvi Rauk
Arvi Rauk
CSClemens von Sonntag
Clemens von Sonntag
The reactions of methanethiyl radicals (CH3S˙) with the cyclic anhydrides of glycine (1a), alanine (L,L-1b and D,L-1b), and sarcosine (1c), and the acyclic peptides, N-formylglycinamide (3a) and N-formylalaninamide (3b), were studied by means of theoretical calculations at the B3LYP/6-311+G(d,p) level of theory. Free energies in the gas phase were determined in the classical harmonic oscillator-rigid rotator model, and used to estimate rates of H-transfer reactions at the αC-site of the peptides. The effects of aqueous solution were estimated by the SCIPCM procedure in combination with modified experimental Arrhenius A-factors to calculate solution phase rate constants. The reactions are discussed in terms of the charge and spin polarisation in the transition state, as determined by AIM analysis. Rate constants calculated by this semiempirical Arrhenius approach are in very good agreement with available experimental data on the reaction of D3N+CH2CH2S˙ with 1a and 1c but not 1b in D2O. The rate constants for the reaction of CH3S˙ with 3a and 3b are also in very good agreement with experimental data on the N-acetyl analogues. Contrary to experiment, the cyclic alanine anhydrides, L,L-1b and D,L-1b, were predicted to react more than an order of magnitude more quickly than any of the other dipeptides.

1 January 2011 in International Journal of Alzheimer's Disease
Verified
Journal Article
Open access
PDF file
SASamira Azimi
Samira Azimi
ARArvi Rauk
Arvi Rauk
Density functional and second order Moller‐Plesset perturbation theoretical methods, coupled with a polarizable continuum model of water, were applied to determine the structures, binding affinities, and reduction potentials of Cu(II) and Cu(I) bound to models of the Asp1, Ala2, His6, and His13His14 regions of the amyloid beta peptide of Alzheimer′s disease. The results indicate that the N‐terminal Asp binds to Cu(II) together with His6 and either His13 or His14 to form the lower pH Component I of Aβ. Component II of Aβ is the complex between Cu(II) and His6, His13, and His14, to which an amide O (of Ala2) is also coordinated. Asp1 does not bind to Cu(II) if three His residues are attached nor to any Cu(I) species to which one or more His residues are bound. The most stable Cu(I) species is one in which Cu(I) bridges the Nδ of His13 and His14 in a linear fashion. Cu(I) binds more strongly to Aβ than does Cu(II). The computed reduction potential that closely matches the experimental value for Cu(II)/Aβ corresponds to reduction of Component II (without Ala2) to the Cu(I) complex after endergonic attachment of His6.